TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more
By: Annette McElhiney
“Resilience presents a challenge for psychologists. Whether you can be said to have it or not largely depends not on any particular psychological test but on the way your life unfolds. If you are lucky enough to … Read more
Lack of exercise is associated with an increased risk of ovarian cancer and of death from the disease, two new studies suggest. “Women may be overwhelmed with mixed messages about physical activity or exercise recommendations and opt to be inactive
… Read moreYou’ve probably heard the adage that you are more likely to regret the things you didn’t do than the things you did. Maybe there’s a long lost love that got away, a career you wish you had pursued, a trip
… Read moreIncreased collaboration and a willingness to see beyond the expected will be critical to the success of the national cancer moonshot initiative, Vice President Joe Biden told ASCO Annual Meeting attendees this afternoon. “No single oncologist or cancer researcher can … Read more
ASCO’s (American Society of Clinical Oncology) Annual Meeting was held on June 2nd through June 7th in Chicago, Illinois. ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide. It showcased new … Read more
Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. … Read more
By: Annette McElhiney
I’ve mentioned frequently, I’m not a medical doctor or a scientific researcher. I’m simply a former nurse, retired college English and Womens Studies Professor, and an 8-year survivor of IIIC ovarian cancer who wants to improve my … Read more
A meta-analysis of 346 phase I clinical trials involving more than 13,000 patients found that patients whose treatment was selected based on the molecular characteristics of their tumor had significantly better outcomes. The study was featured in a press briefing … Read more
Ovarian cancer is a fear of most women, largely due to the abysmal prognosis once it is found. The reasons for this are clearly understood — the more advanced a cancer is when it is discovered, the more difficult it … Read more
By: Annette McElhiney
All my life women have surrounded me— so I am very comfortable in their presence. However, when I received my diagnosis of III C Ovarian Cancer in 2008, I felt like a lone rigid pillar of ice. … Read more
“Ovarian cancer is the most feared gynecologic cancer,” says Teresa Diaz-Montes, MD, associate director of the Lya Segall Ovarian Cancer Institute at Mercy Medical Center in Baltimore, MD. Perhaps that’s for good reason: Often called the “silent killer,” the disease … Read more
Johnson & Johnson is an immense pharmaceutical and consumer products company of the type that the public loves to hate. Recently, it’s been getting absolutely killed by juries holding its baby powder responsible for causing several women’s ovarian cancers. The … Read more
Even as an increasing number of states approve the use of medical marijuana, a review of medical literature and existing data finds that huge questions remain about its true benefits and risks for patients with cancer.1 Investigators found that … Read more
For cancer patients undergoing alopecia-inducing chemotherapy, scalp cooling to reduce hair loss is safe, according to new research. “This is a treatment that women going into chemotherapy treatment need to know about,” said Mikel Ross, RN, BSN, from the Memorial … Read more
By: Annette McElhiney
Most of us are aware of how animals can affect our state of mind both physically and psychologically. For years I taught in an inner city urban college made quite accessible to people who were differently abled. … Read more
Clearity has taken steps to help accelerate molecular matching by enabling women to access the drugs their physicians prescribe to treat their ovarian cancer. The pilot Clearity Match Patient Assistance program that was recently announced helps subsidize the cost of … Read more
By: Cory Bentley, PhD
The Society for Gynecological Oncology (SGO) Meeting this March in San Diego brought together physicians and scientists from all over the world to share the latest research, treatments, and thinking in gynecological cancers including ovarian. Clearity … Read more
Designer will be at two local fashion events; Oasis runway to feature real women, with real bodies
Fashion designer Nicole Miller is known for her figure-flattering silhouettes. She’s also very flattering toward San Diego, where she’ll hold two events this … Read more
Early detection saves lives. If you didn’t go to the grocery store in October or somehow managed to avoid the marketing genius of the Breast Cancer Awareness campaign, then this might be news to you. So here it is once … Read more
